Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BCC 2025 | The importance of survivorship in patients with breast cancer

Tanja Spanic • 13 Mar 2025
BCC 2025
Breast Cancer

Tanja Spanic, PhD, Europa Donna Slovenia, Ljubljana, Slovenia, discusses the significance of patient survivorship after breast cancer diagnosis, and the increase in survival and livelihood. A significant proportion of patients remain active in work and social environments, but continue to face the financial burden of treatment. This interview took place at the 2025 St. Gallen International Breast Cancer Consensus Meeting in Vienna, Austria.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Tanja Spanic

Maintaining patient trust in precision medicine for breast cancer
0:32
Maintaining patient trust in precision medicine for breast cancer
Tanja Spanic • 13 Mar 2025
Incorporating patient perspectives into breast cancer trial design
1:12
Incorporating patient perspectives into breast cancer trial design
Tanja Spanic • 13 Mar 2025
Challenges in precision medicine in early-breast cancer
0:44
Challenges in precision medicine in early-breast cancer
Tanja Spanic • 13 Mar 2025
De-escalating treatment of patients with breast cancer
1:31
De-escalating treatment of patients with breast cancer
Tanja Spanic • 17 Mar 2023

Related Videos

Stress and depression linked to tumor transcriptional signatures in breast cancer
1:21
Stress and depression linked to tumor transcriptional signatures in breast cancer
Shipra Gandhi • 31 May 2026
DESTINY-Breast07: final analysis of T-DXd and durvalumab in 1L HER2+ breast cancer
1:13
DESTINY-Breast07: final analysis of T-DXd and durvalumab in 1L HER2+ breast cancer
Shipra Gandhi • 31 May 2026
TBCRC-053: preoperative radiotherapy & pembrolizumab in node-positive TNBC
1:34
TBCRC-053: preoperative radiotherapy & pembrolizumab in node-positive TNBC
Shipra Gandhi • 1 Jun 2026
HELEN-Trio 011: camrelizumab plus chemotherapy as neoadjuvant therapy in TNBC
0:49
HELEN-Trio 011: camrelizumab plus chemotherapy as neoadjuvant therapy in TNBC
Shipra Gandhi • 1 Jun 2026
The content of VJOncology is intended for healthcare professionals